UA117389C2 - MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION - Google Patents
MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTIONInfo
- Publication number
- UA117389C2 UA117389C2 UAA201607155A UAA201607155A UA117389C2 UA 117389 C2 UA117389 C2 UA 117389C2 UA A201607155 A UAA201607155 A UA A201607155A UA A201607155 A UAA201607155 A UA A201607155A UA 117389 C2 UA117389 C2 UA 117389C2
- Authority
- UA
- Ukraine
- Prior art keywords
- concentrate
- preparation
- infusion solution
- medicinal product
- bioflavonoid
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Винахід належить до медицини та хіміко-фармацевтичної промисловості, зокрема до створення, виробництва та використання лікарських препаратів для лікування серцево-судинних захворювань у вигляді ін'єкцій. Лікарський засіб у формі концентрату для приготування інфузійного розчину містить діючу речовину на основі біофлавоноїду, допоміжні речовини та воду для ін'єкцій, як біофлавоноїд містить дигідрокверцетин, його сполуки і похідні та додатково містить аргінін, а як допоміжні речовини містить полівінілпірролідон з м. м. 8000 або поліетиленоксид 400, або пропіленгліколь 1,2, або їх комбінації.The invention relates to medicine and the chemical-pharmaceutical industry, in particular to the creation, production and use of drugs for the treatment of cardiovascular diseases in the form of injections. The drug in the form of concentrate for the preparation of infusion solution contains the active ingredient based on bioflavonoid, excipients and water for injection, as the bioflavonoid contains dihydroquercetin, its compounds and derivatives and additionally contains arginine, and as excipients contains polyvinylpyrrolidin. 8000 or polyethylene oxide 400, or propylene glycol 1,2, or combinations thereof.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201803421A UA118075C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
| UAA201803422A UA118076C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
| UAA201607155A UA117389C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201607155A UA117389C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA117389C2 true UA117389C2 (en) | 2018-07-25 |
Family
ID=63041298
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201803421A UA118075C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
| UAA201803422A UA118076C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
| UAA201607155A UA117389C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201803421A UA118075C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
| UAA201803422A UA118076C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
Country Status (1)
| Country | Link |
|---|---|
| UA (3) | UA118075C2 (en) |
-
2016
- 2016-07-01 UA UAA201803421A patent/UA118075C2/en unknown
- 2016-07-01 UA UAA201803422A patent/UA118076C2/en unknown
- 2016-07-01 UA UAA201607155A patent/UA117389C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA118076C2 (en) | 2018-11-12 |
| UA118075C2 (en) | 2018-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2017002939A1 (en) | Topical pharmaceutical compositions | |
| HRP20180007T1 (en) | Formulation comprising a gemcitabine-prodrug | |
| EA201101518A1 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY | |
| CY1121698T1 (en) | LIQUID INHALATION PREPARATION CONTAINING RPL554 | |
| NZ727975A (en) | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa | |
| CA3030422C (en) | Stabilizing excipients for therapeutic protein formulations | |
| EA201491479A1 (en) | DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
| BR112018014027A2 (en) | compositions and methods for intravenous administration of 2-bromo-1- (3,3-dinitroazeditin-1-yl) ethanone | |
| EA201792592A1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN | |
| BR112015030315A2 (en) | 4-alkynylimidazole derivative and medicament comprising the same as active ingredient | |
| MX2017004772A (en) | Compositions and methods for physiological delivery using cannabidiol. | |
| EA201792591A1 (en) | PHARMACEUTICAL PREPARATIONS | |
| DOP2016000254A (en) | PHARMECEUTIC FORMULATIONS OF PAN-RAF QUINASE INHIBITOR, PROCEDURES FOR THEIR PREPARATION, AND METHODS OF USE. | |
| NZ701205A (en) | Optimised subcutaneous therapeutic agents | |
| CY1124893T1 (en) | MAROPITANTIS MEDICINAL MIXTURE | |
| MX2016016400A (en) | Stabilized oxymetazoline formulations and their uses. | |
| BR112017022984A2 (en) | device for facilitating the positioning of a catheter to deliver a drug to a spontaneously breathing patient | |
| UA117389C2 (en) | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION | |
| EA201400484A1 (en) | TRANSDERMAL MEANS FOR THE TREATMENT AND PREVENTION OF DISEASES OF JOINT AND SOFT TISSUES | |
| MX2022015232A (en) | Aqueous pharmaceutical composition of levilimab. | |
| MX2018013474A (en) | Carboxylic acids for early childhood application. | |
| EA201600331A1 (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF SOLUTION FOR INTRAVENOUS AND INTRAINAL INTRODUCTION AND METHOD FOR ITS PREPARATION | |
| EA202000253A1 (en) | APPLICATION OF A PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLUTION THAT CONTAINS ARGININE HYDROCHLORIDE AND LEVOCARNITIN FOR THE TREATMENT OF CORONARY HEART DISEASE | |
| MX2016009322A (en) | Meloxicam and methocarbamol solid composition with improved stability. | |
| AR104699A1 (en) | TYPICAL PHARMACEUTICAL COMPOSITION IN EMULSION AND ITS USE TO MANUFACTURE A MEDICINAL PRODUCT |